To study the role of low dose Aspirin in prevention of Preeclampsia
Not Applicable
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2019/05/019232
- Lead Sponsor
- Vss Institute of medical science and research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Pregnant lady( aged 18- 55 years) in 1st trimester between (11th- 14th) wks of gestation with high risk of developing Preeclampsia:
. Women with H/O Preeclampsia.
. Women with chronic hypertension, renal disease
. Obesity:BMI >35kg/m², Insulin resistance
. Pregestational diabetes
. Autoimmune disease
. Hyperplacentosis:Molar pregnancy, multifetal gestation
. Able to provide written. Informed consent.
Exclusion Criteria
. Allergy to salicylates
. Low cardiac reserve, CHF
. Acid peptic disease
. Asthma
. Bleeding diathesis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Aspirin in low dose may be effective in prevention of Preeclampsia and improve feto- maternal outcomesTimepoint: Number of women developing Preeclampsia after 20 wks of gestation
- Secondary Outcome Measures
Name Time Method ow dose aspirin may improve fetal outcomeTimepoint: Number of still birth, preterm birth, neonatal death, NICU admission, fetal growth retardation after delivery